LLY - Eli Lilly and Company

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 375.78B
Enterprise value 390.99B
Trailing P/E 62.93
Forward P/E 46.30
PEG Ratio (5 yr expected) 1.87
Price/sales (ttm)12.92
Price/book (mrq)33.58
Enterprise value/revenue 13.70
Enterprise value/EBITDA 45.15

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 335.84%
S&P500 52-week change 31.77%
52-week high 3454.95
52-week low 3283.11
50-day moving average 3387.29
200-day moving average 3350.87

Share statistics

Avg vol (3-month) 33.31M
Avg vol (10-day) 32.96M
Shares outstanding 5949.27M
Implied shares outstanding 6N/A
Float 8947.4M
% held by insiders 10.15%
% held by institutions 184.00%
Shares short (14 May 2023) 46.1M
Short ratio (14 May 2023) 41.77
Short % of float (14 May 2023) 40.77%
Short % of shares outstanding (14 May 2023) 40.64%
Shares short (prior month 13 Apr 2023) 47.57M

Dividends & splits

Forward annual dividend rate 44.52
Forward annual dividend yield 41.06%
Trailing annual dividend rate 34.07
Trailing annual dividend yield 30.95%
5-year average dividend yield 41.68
Payout ratio 464.71%
Dividend date 308 Jun 2023
Ex-dividend date 411 May 2023
Last split factor 22:1
Last split date 315 Oct 1997

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 20.54%
Operating margin (ttm)27.82%

Management effectiveness

Return on assets (ttm)9.62%
Return on equity (ttm)54.79%

Income statement

Revenue (ttm)27.69B
Revenue per share (ttm)30.73
Quarterly revenue growth (yoy)-10.90%
Gross profit (ttm)21.91B
EBITDA 9.15B
Net income avi to common (ttm)5.69B
Diluted EPS (ttm)6.30
Quarterly earnings growth (yoy)-29.30%

Balance sheet

Total cash (mrq)3.72B
Total cash per share (mrq)3.92
Total debt (mrq)18.99B
Total debt/equity (mrq)168.09
Current ratio (mrq)1.30
Book value per share (mrq)12.44

Cash flow statement

Operating cash flow (ttm)6.29B
Levered free cash flow (ttm)5.21B